Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
Nanyue Biopharmaceutical Corporation Ltd, Hengyang, Hunan, China.
Vox Sang. 2024 Feb;119(2):144-154. doi: 10.1111/vox.13572. Epub 2023 Dec 28.
The present study aims to evaluate the iron stores in plasmapheresis donors and develop and validate an iron deficiency (ID) risk prediction model for plasmapheresis donors with potential or existing ID.
We assessed plasmapheresis donors' serum ferritin (SF) and haemoglobin (Hb) levels. The candidate factors showing significant differences in the multivariate logistic regression analysis were used to establish a risk prediction scoring system. The participants were divided into a training cohort and an internal validation cohort in a 7:3 ratio. Additional plasmapheresis donors from a different station were recruited for external validation.
The SF levels in both male and female donors in the high-frequency group were significantly lower than those of new donors (male: p < 0.001; female: p = 0.008). The prevalence of ID in female regular donors with a high frequency was significantly higher than that in new donors (33.1% vs. 24.6%; odds ratio = 1.209 [95% CI: 1.035-1.412]). Donation frequency, age, Hb, body mass index and being pre-menopausal were identified as independent risk factors for ID (p < 0.05). The developed model exhibited good discrimination ability (area under the receiver operating characteristic curve >0.7) and calibration (p > 0.05) in development, internal validation cohorts and external validation cohorts.
A higher donation frequency has been associated with reduced SF levels and an increased risk of ID in women. The developed ID risk prediction model demonstrates moderate discriminative power and good model fitting, suggesting its potential clinical utility.
本研究旨在评估血浆捐献者的铁储存量,并为潜在或现有的缺铁(ID)的血浆捐献者开发和验证 ID 风险预测模型。
我们评估了血浆捐献者的血清铁蛋白(SF)和血红蛋白(Hb)水平。多元逻辑回归分析中显示显著差异的候选因素用于建立风险预测评分系统。参与者以 7:3 的比例分为训练队列和内部验证队列。从另一个站点招募额外的血浆捐献者进行外部验证。
高频组男性和女性供体的 SF 水平明显低于新供体(男性:p<0.001;女性:p=0.008)。高频女性规律供体的 ID 患病率明显高于新供体(33.1%比 24.6%;优势比=1.209[95%CI:1.035-1.412])。献血频率、年龄、Hb、体重指数和绝经前状态被确定为 ID 的独立危险因素(p<0.05)。开发的模型在开发、内部验证队列和外部验证队列中均显示出良好的区分能力(接受者操作特征曲线下面积>0.7)和校准(p>0.05)。
较高的献血频率与女性 SF 水平降低和 ID 风险增加相关。开发的 ID 风险预测模型具有中等的判别能力和良好的模型拟合度,提示其具有潜在的临床应用价值。